Angiogenesis Inhibitors for the Treatment of Ovarian Cancer: An Updated Systematic Review and Meta-analysis of Randomized Controlled Trials

BACKGROUND: Angiogenesis inhibitors showed activity in ovarian cancer, but preliminary data could not accurately reflect the survival benefit. We thus did a systematic review and meta-analysis of randomized controlled trials to reassess the efficacy and safety of angiogenesis inhibitors combined wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Haihong, Xu, Tie, Zheng, Lifen, Li, Guiling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2018
Materias:
Ovarian Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976222/
https://www.ncbi.nlm.nih.gov/pubmed/29561301
http://dx.doi.org/10.1097/IGC.0000000000001258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976222/
https://www.ncbi.nlm.nih.gov/pubmed/29561301
http://dx.doi.org/10.1097/IGC.0000000000001258

Ejemplares similares